FDA Approved: NITROFURANTOIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA granted supplemental approval for nitrofurantoin filed by Amneal Pharmaceuticals NY LLC (ANDA201679), authorizing its marketing as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis
• Urinary Tract Infection

Drugs mentioned

• Nitrofurantoin (Nitrofurantoin)

Snippet

SUPPL AP for NITROFURANTOIN (NITROFURANTOIN)